GERRESHEIMER AG (GXI.DE) Fundamental Analysis & Valuation
FRA:GXI • DE000A0LD6E6
Current stock price
17.05 EUR
-0.53 (-3.01%)
Last:
This GXI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GXI.DE Profitability Analysis
1.1 Basic Checks
- GXI had positive earnings in the past year.
- In the past year GXI had a positive cash flow from operations.
- Each year in the past 5 years GXI has been profitable.
- Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of GXI (0.50%) is worse than 76.19% of its industry peers.
- Looking at the Return On Equity, with a value of 1.67%, GXI is doing worse than 71.43% of the companies in the same industry.
- GXI has a Return On Invested Capital of 2.79%. This is in the lower half of the industry: GXI underperforms 76.19% of its industry peers.
- GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is significantly below the industry average of 12.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
- GXI has a Profit Margin of 1.04%. This is in the lower half of the industry: GXI underperforms 76.19% of its industry peers.
- In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
- GXI has a worse Operating Margin (5.99%) than 76.19% of its industry peers.
- In the last couple of years the Operating Margin of GXI has grown nicely.
- With a Gross Margin value of 26.89%, GXI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. GXI.DE Health Analysis
2.1 Basic Checks
- GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, GXI has about the same amount of shares outstanding.
- The number of shares outstanding for GXI has been increased compared to 5 years ago.
- The debt/assets ratio for GXI is higher compared to a year ago.
2.2 Solvency
- GXI has an Altman-Z score of 0.90. This is a bad value and indicates that GXI is not financially healthy and even has some risk of bankruptcy.
- GXI has a Altman-Z score of 0.90. This is in the lower half of the industry: GXI underperforms 76.19% of its industry peers.
- A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.22, GXI is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.9 |
ROIC/WACC0.37
WACC7.48%
2.3 Liquidity
- GXI has a Current Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
- GXI has a worse Current ratio (0.98) than 71.43% of its industry peers.
- GXI has a Quick Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.52, GXI is doing worse than 80.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. GXI.DE Growth Analysis
3.1 Past
- The earnings per share for GXI have decreased strongly by -19.08% in the last year.
- Measured over the past years, GXI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
- The Revenue has grown by 11.83% in the past year. This is quite good.
- The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
- GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.46% yearly.
- Based on estimates for the next years, GXI will show a small growth in Revenue. The Revenue will grow by 6.99% on average per year.
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.99%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GXI.DE Valuation Analysis
4.1 Price/Earnings Ratio
- GXI is valuated cheaply with a Price/Earnings ratio of 4.62.
- 100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
- GXI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.91.
- GXI is valuated cheaply with a Price/Forward Earnings ratio of 6.51.
- GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.62 | ||
| Fwd PE | 6.51 |
4.2 Price Multiples
- GXI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GXI is cheaper than 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.63 |
4.3 Compensation for Growth
- GXI's earnings are expected to decrease with -8.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
5. GXI.DE Dividend Analysis
5.1 Amount
- GXI has a yearly dividend return of 0.19%, which is pretty low.
- The stock price of GXI dropped by -35.84% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 0.45, GXI has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.89, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
- The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
- 10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
- GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
GXI.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:GXI (4/9/2026, 4:24:26 PM)
17.05
-0.53 (-3.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26 2026-02-26/amc
Earnings (Next)04-16 2026-04-16
Inst Owners91.76%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap588.91M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts52.73
Price Target32.54 (90.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-6.02%
PT rev (3m)-15.6%
EPS NQ rev (1m)-94.61%
EPS NQ rev (3m)-316.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.66%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.62 | ||
| Fwd PE | 6.51 | ||
| P/S | 0.26 | ||
| P/FCF | N/A | ||
| P/OCF | 2.32 | ||
| P/B | 0.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.63 |
EPS(TTM)3.69
EY21.64%
EPS(NY)2.62
Fwd EY15.36%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY43.07%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.9 |
F-Score4
WACC7.48%
ROIC/WACC0.37
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year12.78%
Revenue Next 2Y7.56%
Revenue Next 3Y6.88%
Revenue Next 5Y6.99%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year81.16%
EBIT Next 3Y29.65%
EBIT Next 5Y20.08%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status for GXI stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for GERRESHEIMER AG?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for GXI stock?
The Price/Earnings (PE) ratio for GERRESHEIMER AG (GXI.DE) is 4.62 and the Price/Book (PB) ratio is 0.42.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.